Eton Announces FDA Approval Of Seizure Medication Zonisade

Eton Pharmaceuticals, Inc. (ETON) on Monday said that the Food and Drug Administration approved ZONISADE, the oral liquid formulation of zonisamide, used as a capsule to treat partial seizures in patients with epilepsy.

As per the multi-product neurology oral solution partnership signed with Azurity Pharmaceuticals in February 2021, Eton is entitled to receive an additional $5 million upon the launch of ZONISADE, royalty on net sales, and up to $15 million on reaching certain sales milestones of all three products in the partnership.

Commercialization of ZONISADE will be done by Azurity, Eton said.

"ZONISADE is the first and only FDA-approved oral liquid formulation of zonisamide, and it offers healthcare providers an important new treatment option for their patients with epilepsy," said Richard Blackburn, CEO of Azurity Pharmaceuticals.

ETON is up more than 17% in pre-market. The stock closed at $2.79, up 3.72% on Friday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration said it now intends to review only a small subset of new emergency use authorization or EUA requests for diagnostic tests. As per an updated COVID-19 test policy with a view to ensure continued access to tests, the regulator further urged developers of all test types seeking marketing authorization to pursue traditional premarket review for most test types. Netflix, Inc. said it is adding a new feature to offer a more personalized mobile games experience on the platform. In a statement, Sophia Yang, Product Manager, Mobile Games, said the company is rolling out the ability to create game handles, with which members will be able to create a unique public username. This can be used across all Netflix games. General Motors Co. has delayed its plan to require employees to return to office many days a week until next year, reports said citing an internal memo signed by CEO Mary Barra. Last week, the company had announced that corporate workers would be required to return to respective offices at least three days a week, beginning later this year, as the COVID-19 pandemic eases.
Follow RTT